Glucocorticoid selection for pediatric ALL.

In this issue of Blood, Möricke et al report findings from the Associazione Italiana di Ematologia e Oncologia Pediatrica-Berlin-Frankfurt-Münster (AIEOP-BFM) acute lymphoblastic leukemia (ALL) 2000 clinical trial that substituting dexamethasone for prednisone during induction chemotherapy for children and adolescents with ALL improved event-free survival (EFS), but had no impact on overall survival (OS).1 [ABSTRACT FROM AUTHOR]